Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Agnelli

Showing results (11-20 of 202) with videos related to

Pageof 21
Sort By:
Minerva Cardioangiologica|February 18, 1999
[Therapeutic aspects and secondary prevention of deep vein thrombosis]G Agnelli
Haematologica|July 25, 2000
Clinical significance of non clinical end-points in studies on the prevention of venous thromboembolismG Agnelli
Vascular Medicine (London, England)|January 16, 2002
Rationale for the use of platelet aggregation inhibitors in PAD patientsG Agnelli
International Journal of Cardiology|August 1, 1995
Thrombolytic and antithrombotic treatment in myocardial infarction: main achievements and future perspectivesG Agnelli
Haematologica|March 1, 1995
Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?G Agnelli
Chest|April 1, 1990
Rationale for bolus t-PA therapy to improve efficacy and safetyG Agnelli
Minerva Cardioangiologica|January 21, 2000
[Deep vein thrombosis: present and future drugs]G Agnelli
Thrombosis and Haemostasis|July 1, 1997
Venous thromboembolism and cancer: a two-way clinical associationG Agnelli
Seminars in Hematology|July 13, 2001
Clinical and economic aspects of managing venous thromboembolism in the outpatient settingG Agnelli, C Becattini
Cardiologia (Rome, Italy)|December 25, 2002
[Current role of phlebography for the diagnosis of deep venous thrombosis]G Agnelli, R Rossi
Pageof 21

Showing results (11-20 of 202) with videos related to

Sort By:
Pageof 21
Minerva Cardioangiologica|February 18, 1999
[Therapeutic aspects and secondary prevention of deep vein thrombosis]G Agnelli
Haematologica|July 25, 2000
Clinical significance of non clinical end-points in studies on the prevention of venous thromboembolismG Agnelli
Vascular Medicine (London, England)|January 16, 2002
Rationale for the use of platelet aggregation inhibitors in PAD patientsG Agnelli
International Journal of Cardiology|August 1, 1995
Thrombolytic and antithrombotic treatment in myocardial infarction: main achievements and future perspectivesG Agnelli
Haematologica|March 1, 1995
Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?G Agnelli
Chest|April 1, 1990
Rationale for bolus t-PA therapy to improve efficacy and safetyG Agnelli
Minerva Cardioangiologica|January 21, 2000
[Deep vein thrombosis: present and future drugs]G Agnelli
Thrombosis and Haemostasis|July 1, 1997
Venous thromboembolism and cancer: a two-way clinical associationG Agnelli
Seminars in Hematology|July 13, 2001
Clinical and economic aspects of managing venous thromboembolism in the outpatient settingG Agnelli, C Becattini
Cardiologia (Rome, Italy)|December 25, 2002
[Current role of phlebography for the diagnosis of deep venous thrombosis]G Agnelli, R Rossi
Pageof 21